实用心电与临床诊疗2026，Vol.35Issue(1)：144-151,8.DOI:10.13308/j.issn.2097-5716.xd20250386
起搏诱导性心肌病的临床研究进展
Advances in clinical research of pacing-induced cardiomyopathy
摘要
Abstract
Pacemaker-induced cardiomyopathy(PICM)is a serious complication characterized by progressive deterioration of left ventricular systolic function due to chronic right ventricular pacing.With the annual increase in permanent pacemaker implantations,the early identification and effective management of PICM have become key concerns in the field of cardiology.This article systematically reviews the definition,epidemiological features,pathophysiological mechanisms,risk factors,and related predictive models of PICM.Based on current evidences,it evaluates the effect and limitations of preventive and therapeutic strategies including cardiac resynchronization therapy,conduction system pacing,and biological pacing,aiming to provide insights for clinical practice.关键词
起搏诱导性心肌病/右心室起搏/永久性心脏起搏器/心脏再同步化治疗/传导系统起搏Key words
pacing-induced cardiomyopathy/right ventricular pacing/permanent pacemaker/cardiac resynchronization therapy/conduction system pacing分类
医药卫生引用本文复制引用
张磊,徐素丹,李红莉..起搏诱导性心肌病的临床研究进展[J].实用心电与临床诊疗,2026,35(1):144-151,8.基金项目
上海交通大学医工交叉重点项目(YG2021ZD19) （YG2021ZD19）
